Nature’s Sunshine Products (NASDAQ:NATR) EVP Daniel Norman Sells 9,713 Shares

Nature’s Sunshine Products, Inc. (NASDAQ:NATR) EVP Daniel Norman sold 9,713 shares of the stock in a transaction that occurred on Monday, June 1st. The stock was sold at an average price of $20.64, for a total value of $200,476.32. Following the transaction, the executive vice president owned 47,276 shares in the company, valued at approximately $975,776.64. This trade represents a 17.04% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

Nature’s Sunshine Products Price Performance

NATR opened at $19.90 on Thursday. The business has a fifty day simple moving average of $24.30 and a 200 day simple moving average of $23.83. Nature’s Sunshine Products, Inc. has a 1 year low of $12.97 and a 1 year high of $28.14. The company has a market capitalization of $349.84 million, a PE ratio of 18.09 and a beta of 0.86.

Nature’s Sunshine Products (NASDAQ:NATR) last posted its quarterly earnings data on Thursday, May 7th. The company reported $0.30 earnings per share for the quarter, topping the consensus estimate of $0.20 by $0.10. The firm had revenue of $122.89 million for the quarter, compared to analysts’ expectations of $122.15 million. Nature’s Sunshine Products had a return on equity of 14.67% and a net margin of 4.06%.

Institutional Investors Weigh In On Nature’s Sunshine Products

Several institutional investors and hedge funds have recently bought and sold shares of the company. Jane Street Group LLC bought a new position in Nature’s Sunshine Products in the 1st quarter valued at about $174,000. Geode Capital Management LLC lifted its holdings in shares of Nature’s Sunshine Products by 9.4% during the 2nd quarter. Geode Capital Management LLC now owns 317,731 shares of the company’s stock worth $4,700,000 after acquiring an additional 27,300 shares during the period. JPMorgan Chase & Co. boosted its position in shares of Nature’s Sunshine Products by 16.1% during the 2nd quarter. JPMorgan Chase & Co. now owns 228,698 shares of the company’s stock worth $3,382,000 after acquiring an additional 31,696 shares in the last quarter. Rhumbline Advisers increased its stake in Nature’s Sunshine Products by 9.7% in the second quarter. Rhumbline Advisers now owns 21,180 shares of the company’s stock valued at $313,000 after acquiring an additional 1,875 shares during the last quarter. Finally, Russell Investments Group Ltd. increased its stake in Nature’s Sunshine Products by 91.9% in the second quarter. Russell Investments Group Ltd. now owns 23,787 shares of the company’s stock valued at $348,000 after acquiring an additional 11,389 shares during the last quarter. Institutional investors own 79.40% of the company’s stock.

Analyst Ratings Changes

NATR has been the subject of several analyst reports. Weiss Ratings cut shares of Nature’s Sunshine Products from a “buy (b)” rating to a “buy (b-)” rating in a research note on Tuesday, May 26th. DA Davidson reaffirmed a “buy” rating and set a $33.00 target price on shares of Nature’s Sunshine Products in a report on Monday, May 11th. Finally, Canaccord Genuity Group set a $37.00 price target on shares of Nature’s Sunshine Products in a research report on Friday, May 8th. Three research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, Nature’s Sunshine Products has a consensus rating of “Buy” and a consensus price target of $35.00.

Nature’s Sunshine Products Company Profile

Nature’s Sunshine Products, Inc is a global manufacturer and direct seller of nutritional supplements, herbal remedies, and personal care products. The company’s core business centers on research, development and distribution of vitamins, minerals, botanicals and essential oil-based formulations designed to support overall health and wellness. Operating under a network-marketing model, Nature’s Sunshine works through a network of independent distributors who promote and sell its product line directly to consumers.

The company’s product portfolio spans dietary supplements such as single-ingredient vitamins, proprietary herbal blends, sports nutrition formulas and weight-management solutions, along with skin and hair care items based on botanical extracts and essential oils.